Notal Vision is a privately held ophthalmic company focused on advancing eye care with precision medicine by extending disease management from the clinic to the home.
Notal Vision is the first diagnostic services company to extend eye disease management from the clinic to the home and improve vision outcomes.
Notal Vision was founded in 2000. The company is headquartered in Manassas, Virginia, with an office in Tel Aviv, Israel.
Notal Vision has proven approach to home-based patient operated diagnostics and artificial intelligence (AI) enabled data analysis, we are advancing eye care with precision medicine.
Notal Vision’s Home OCT enables exudative AMD patients to perform technician-free OCT testing at home with rapid, self-guided fixation – critical components, especially for elderly patients frequently with pre-existing vision loss.
The Notal OCT Analyzer (NOATM), a proprietary machine learning algorithm, developed in-house, performs automated analysis of the Home OCT scans and generates a report to the physician when a physician specified change in disease activity is detected. The Notal Vision Diagnostic Clinic sends reports to the treating physician which characterize quantitative changes in fluid. In addition, physicians will be provided 24/7 access to all B-scan images from each home OCT test with the location of the fluid annotated on each B-scan.
Notal Vision is backed by Ganot Capital, Elron Electronic Industries, Innomed Ventures and others. The company raised $25m in a latest financing on Dec 11, 2019. This brings Notal Vision's total funding to $75M to date.